StoneRidge PMG Advisors, LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
StoneRidge PMG Advisors, LLC's REGN Position: Q3 2026 in Review
StoneRidge PMG Advisors, LLC opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 804 shares worth $610K. The stake represents 0.43% of the portfolio and ranks #63 among its holdings.
1,423 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- StoneRidge PMG Advisors, LLC held 804 shares of Regeneron Pharmaceuticals worth $610K as of Q3 2026.
- Regeneron Pharmaceuticals was a new StoneRidge PMG Advisors, LLC position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.43% of StoneRidge PMG Advisors, LLC's portfolio in Q3 2026, its #63 holding.
- 1,423 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on StoneRidge PMG Advisors, LLC's 13F filing for Q3 2026, filed 4 Nov 2026.